Diasorin SpA (OTCPK:DSRLF)
$ 109 0 (0%) Market Cap: 5.40 Bil Enterprise Value: 6.37 Bil PE Ratio: 30.77 PB Ratio: 3.12 GF Score: 98/100

Q2 2022 DiaSorin SpA Earnings Call Transcript

Aug 03, 2022 / 01:00PM GMT
Release Date Price: $144.11
Operator

Good afternoon. This is the Chorus Call conference operator. Welcome and thank you for joining the DiaSorin First Half 2022 Results Conference Call. (Operator Instructions)

At this time, I would like to turn the conference over to Mr. Carlo Rosa, CEO of DiaSorin. Please go ahead, sir.

Carlo Rosa
DiaSorin S.p.A. - CEO, GM & Executive Director

Thank you operator. Ladies and gentlemen, good morning, and welcome to the H1 conference call. I'm going to make the initial remarks on the top line by geography and by technology and then I'm going to make a few comments on some of the major events that happened in the quarter, and then I'm going to leave to our CFO for the commentary on the numbers.

So starting from the technology. I will discuss immuno, I will discuss molecular, I will talk about license technology, and this last but not least, I will talk about COVID.

When it comes to immuno, which I remind everybody it includes our CLIA reagents as well our residual ELISA business franchise in H1 this plus 5% which is in line with our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot